Terumo

Healthcare & biotech / Medical Devices and Healthcare Technology

🚀 Founded 1921 🌎 Japan 🏷️ TRUMF JP3546800008 ⭐ 10000 DCF 13.81 💰14.67

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights (3) 🏢 Company Q&A (465) 🛠️ Industry Q&A (98) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

⚖️ Balance Sheet 💵 Income Statement 🔄 Cash Flow 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

🔥 Video Insights

[Disclaimer]

Terumo’s Stock Dips – Is It a Hidden Opportunity?

September 30, 2025

An in-depth value-focused review of Terumo, exploring why its stock is down, recent financial performance, dividends, risks, and potential recovery. Essential insights for investors seeking informed decisions.

Why Terumo’s Stock Price Is Surprisingly Low — Hidden Value in Medical Tech?

July 8, 2025

In this video, we explore why Terumo’s stock price remains low despite record revenues, strong margins, and steady dividend growth. We break down key products, financial performance, growth drivers, risks and value potential — all in a clear, jargon‑free way. This review is for educational purposes only. Subscribe for more sharp, data‑driven stock insights from InsightfulValue.

Terumo’s Stock Price Dips—Is This Medical Giant an Overlooked Opportunity?

June 2, 2025

Discover why Terumo’s stock price is low and what that means for investors. We analyze this global medical technology leader’s business model, financial health, and growth outlook to help you make more informed investment choices.

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.